Caroline Richards at BioWorld explores how our AI-driven approach is enabling TCR discovery and optimisation at unprecedented scale and speed.
Etcembly aims at cancer with AI-driven, rapid TCR engineering technology
top of page
bottom of page
Caroline Richards at BioWorld explores how our AI-driven approach is enabling TCR discovery and optimisation at unprecedented scale and speed.
Comments